Section Arrow
Quote
HCM.NASDAQ
- HUTCHMED (China) Limited
Quotes are at least 15-min delayed:2026/09/26 23:41 EDT
Regular Hours
Last
 13.94
+0.04 (+0.29%)
Day High 
14.14 
Prev. Close
13.9 
1-M High
14.55 
Volume 
71.26K 
Bid
13.82
Ask
14.98
Day Low
13.915 
Open
14.06 
1-M Low
11.8 
Market Cap 
2.42B 
Currency 美元 
P/E 139 
%Yield -- 
10-SMA 13.8 
20-SMA 13.38 
50-SMA 12.43 
52-W High 16.4 
52-W Low 9.77 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.10/0.59
Enterprise Value
2.49B
Balance Sheet
Book Value Per Share
7.25
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
548.51M
Operating Revenue Per Share
4.36
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
APUSApimeds Pharmaceuticals US Inc.7.25+2.33+47.36%-- 
HLNHaleon plc9.26+0.04+0.43%19.28PE
VTRSViatris17.83+0.41+2.35%-- 
HIMSHims & Hers Health29.42+0.14+0.48%-- 
ELANElanco Animal Health22.31-0.04-0.18%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.